- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 5.1 EX-5.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 23.1 EX-23.1
- EX-FILING FEES Ex-filing Fees
- Download Excel data file
- View Excel data file
- 17 May 24 424B3 Prospectus supplement
- 1 May 24 EFFECT Notice of effectiveness
- 30 Apr 24 424B3 Prospectus supplement
- 18 Apr 24 POS AM Prospectus update (post-effective amendment)
- 8 Nov 23 424B3 Prospectus supplement
- 21 Sep 23 424B3 Prospectus supplement
- 8 Sep 23 EFFECT Notice of effectiveness
- 28 Aug 23 S-1/A IPO registration (amended)
-
27 Jul 23 S-1 IPO registration
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement to Form S-1 of our audit report dated March 31, 2023, with respect to the balance sheets of Monogram Orthopaedics, Inc. as of December 31, 2022 and 2021, and the related statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2022.
Our report relating to those financial statements includes an emphasis of matter paragraph regarding substantial doubt as to the Company’s ability to continue as a going concern.
We also consent to the reference to us under the heading “Experts” in such Registration Statement.
Spokane, Washington
July 25, 2023